03:22 AM EDT, 10/28/2024 (MT Newswires) -- J Matthew Singleton, Director, on October 25, 2024, sold 16,000 shares in Viking Therapeutics ( VKTX ) for $1,272,000. Following the Form 4 filing with the SEC, Singleton has control over a total of 9,500 shares of the company, with 9,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1607678/000095017024117513/xslF345X05/ownership.xml

Price: 77.75, Change: -0.28, Percent Change: -0.36